Study Shows DSC MRI Perfusion Distinguishes Tumor from Non-Tumor TissueMILWAUKEE, WI / ACCESSWIRE / May 3, 2022 / Imaging Biometrics,…
VANCOUVER, BC / ACCESSWIRE / May 3, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is…
CHICAGO, IL / ACCESSWIRE / May 3, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with…
HENDERSON, NV / ACCESSWIRE / May 3, 2022 / EVIO, Inc. (OTC PINK:EVIO) announced today that the company has entered…
HACKENSACK, NJ / ACCESSWIRE / May 3, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is…
Canalevia® Would Be the First and Only Treatment for EID in Dogs To Receive Any Type of Approval From FDASAN…
Company Invites Investors, Analysts, and Advisors to Attend Its In-Person and Webcast Presentation on Wednesday, May 4, 2022 at 11:30am…
SAN DIEGO, CA / ACCESSWIRE / May 3, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), today…
TORONTO, ON / ACCESSWIRE / May 3, 2022 / Highmark Interactive Inc. (TSX.V:HMRK) ("Highmark"), a global leader in digital health…
TORONTO, ON / ACCESSWIRE / May 3, 2022 / GHP Noetic Science-Psychedelic Pharma Inc. (TSXV:PSYF.P) ("GHP"), a capital pool company,…